<qa>  What is the PHASE 3 MULTI-CENTER STUDY of GEA PHASE 3, MULTI-CENTER STUDY OF GEMCITABINECARBOPLATIN, WITH OR WITHOUT BSI-201, IN PATIENTS WITH ER-, PR-, AND HER2-NEGATIVE METASTATIC BREAST CANCER: 